Novel Hsp90 partners discovered using complementary proteomic approaches

Cell Stress and Chaperones

Volumn 14, Issue 6, 2009, Pages 629-638

  Tsaytler, Pavel A ^a   Krijgsveld, Jeroen ^a   Goerdayal, Soenita S ^a   Rüdiger, Stefan ^a   Egmond, Maarten R ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Heat shock protein 90; Identification; Immobilization; Interactome; Kinase; Partners

Indexed keywords

BINDING PROTEIN; CYCLIN DEPENDENT KINASE 3; GELDANAMYCIN; HEAT SHOCK PROTEIN 90; SEPHAROSE; TOM34 PROTEIN; TRIPARTITE MOTIF PROTEIN 29; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN IMMOBILIZATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEOMICS; TETRATRICOPEPTIDE REPEAT;

AMINO ACID MOTIFS; CELL LINE, TUMOR; CONSENSUS SEQUENCE; CYCLIN-DEPENDENT KINASE 3; DNA-BINDING PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOPRECIPITATION; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; PROTEIN BINDING; PROTEOMICS; TRANSCRIPTION FACTORS;

EUKARYOTA;

EID: 77950806427     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1007/s12192-009-0115-z     Document Type: Article

References (40)

1. Ali MM, Roe SM, Vaughan CK, Meyer P, Panaretou B, Piper PW, Prodromou C, Pearl LH (2006) Crystal structure of an Hsp90nucleotide-p23/Sba1 closed chaperone complex. Nature 440:10131017. doi: 10.1038/nature04716
2. Caplan AJ, Mandal. AK, Theodoraki MA (2007) Molecular chaperones and protein kinase quality control. Trends Cell Biol 17:87-92. doi:10.1016/j.tcb. 2006.12.002 (Pubitemid 46199182)
3. Chadli A, Felts SJ, Toft DO (2008) GCUNC45 is the first Hsp90 cochaperone to show alpha/beta isoform specificity. J Biol Chem 283:9509-9512. doi:10.1074/jbc.C800017200
4. Citri A, Harari D, Shohat G, Ramakrishnan P, Gan J, Lavi S, Eisenstein M, Kimchi A, Wallach D, Pietrokovski S, Yarden Y (2006) Hsp90 recognizes a common surface on client kinases. J Biol Chem 281:14361-14369. doi:10.1074/jbc. M512613200 (Pubitemid 43848365)
5. Crevel G, Bennet D, Cotteril S (2008) The human TPR protein TTC4 is a putative Hsp90 co-chaperone which interacts with Cdc6 and shows alterations in transformed cells. PLoS One 3:1-10. doi: 10.1371/journal.pone.0001737
6. Falsone SF, Gesslbauer B, Tirk F, Piccinini A, Kungl AJ (2005) A proteomic snapshot of the human heat shock protein 90 interactome. FEBS Lett 579:6350-6354. doi:10.1016/j.febslet 2005.10.020 (Pubitemid 41612151)
7. Fan ACY, Bhangoo MK, Young JC (2006) Hsp90 fonctions in the targeting and outer membrane translocation steps of Tom70mediated mitochondrial import. J Biol Chem 281:33313-33324. doi:10.1074/jbc.M605250200
8. Kosaka Y, Inoue H, Ohmachi T, Yokoe T, Matsumoto T, Minori K, Tanaka F, Watanabe M, Mori M (2007) Tripartite motifcontaining 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer. Ann Surg Oncol 14:2543-2549. doi:10.1245/s10434-007-9461-l (Pubitemid 47389583)
9. Lamphere L, Fiore F, Xu X, Brizuela L, Keezer S, Sardet C, Draetta GF, Gyuris J (1997) Interaction between Cdc37 and Cdk4 in human cells. Oncogene 14:1999-2004. doi: 10.1038/sj.onc. 1201036 (Pubitemid 27217814)
10. Lotz GP, Brychzy A, Heinz S, Obermann WM (2008) J Cell Sci 121:717-723. doi: 10.1242/jcs.015610
11. McClellan AJ, Xia Y, Deutschbauer AM, Davis RW, Gerstein M, Frydman J (2007) Diverse cellular functions of the Hsp90 molecular chaperone uncovered, using systems approaches. Cell 131:121-135. doi: 10.1016/j.cell.2007.07.036 (Pubitemid 47498528)
12. Millson SH, Truman AW, King V, Prodromou C, Pearl LH, Piper PW (2005) A two-hybrid screen of the yeast proteome for Hsp90 interactors uncovers a novel Hsp90 chaperone requirement in the activity of a stress-activated mitogen-activated protein kinase, Slt2p (Mpk1p). Eukar Cell 4:849-860. doi:10.1128/EC.4.5.849-860.2005 (Pubitemid 40697749)
13. Modi S, Stopeck AT, Gordon MS, Mendelson D, Solit DB, Bagatell R, Ma W, Wheler J, Rosen N, Norton L, Cropp GF, Johnson RG, Hannah. AL, Hudis CA (2007) Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study. J Clin Oncol 25(Modi, S., Stopeck, A.T., Gordon, M.S., Mendelson, D., Solit, D.B., Bagateli, R., Ma, W., Wheler, J., Rosen, N., Norton, L., Cropp, G.F., Johnson, R.G., Hannah, A.L., and Hudis, C.A):5410-5417. doi:10.1200/ JCO.2007.11.7960
14. Nisole S, Stoye JP, Saib A. (2005) TRIM family proteins: retroviral restriction and antiviral defense. Nat Rev Microbiol 3:799-808. doi:10.1038/nrmicro1248 (Pubitemid 41518740)
15. Pearl LH, Prodromou. C, Workman P (2008) The Hsp90 molecular chaperone: an open and shut case for treatment. Biochem J 410:439-453. doi: 10.1042/BJ20071640 (Pubitemid 351429015)
16. Pratt WB, Toil DO (2003) Regulation of signaling protein function and trafficking by Hsp90/Hsp70-based chaperone machinery. Exp Biol Med 228:11-133
17. Prince T, Matts RL (2004) Definition of protein kinase sequence that trigger high affinity binding of Hsp90 and Cdc37. J Biol Chem 279:39975-39981. doi: 10.1074/jbc.M406882200 (Pubitemid 39258271)
18. Prince T, Sun L, Matts RL (2006) Cdk2: a genuine protein kinase client of Hsp90 and Cdc37. Biochem 44:15287-15295 (Pubitemid 41681463)
19. Ramalingam SS, Egorin MG, Ramanathan RK, Remick SC, Sikorski RP, Lagattuta TF, Chatta GS, Friedland dM, Stoller RG, Potter DM, Ivy SP, Belani CP (2008) A phase I study of 17-allylamino17-demethoxygeldanamycin combined with, paclitaxel in patients with advanced solid malignancies. Clin Cancer Res 14:3456-3461. doi: 10.1158/1078-0432.CCR-07-5088
20. Richter K, Muschler P, Hainzl O, Reinstein J, Buchner J (2003) Stil is a non-competitive inhibitor of the Hsp90 ATPase. J Biol Chem 278:10328-10333. doi:10.1074/jbc.M213094200
21. Roe SM, Ali MMU, Meyer P, Vaughan CK, Panaretou B, Piper PW, Prodromou C, Pearl L (2004) The mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50cdc37. Cell 116:87-98. doi:10.1016/S0092-8674(03)01027-4 (Pubitemid 38156186)
22. Rüdiger S, Freund SM, Verprintsev DB, Fersht AR (2002) CRINEPTTROSY NMR reveals p53 core domain bound in an unfolded form to the chaperone Hsp90. Proc Natl. Acad Sci USA 99:11085-11090. doi:10.1073/pnas.132393699 (Pubitemid 34920883)
23. Schlatter H, Langer T, Rosmus S, Onneken ML, Fasold H (2002) A novel function for the Hsp90 kDa heat-shock protein (Hsp90): facilitating nuclear export of 60 S ribosomal subunits. Biochem J 362:675-684. doi: 10.1042/0264-6021:3620675 (Pubitemid 34242319)
24. Schlegel T, Minis O, von Haeseler A, Schleiff E (2007) The tetratricopeptide repeats of receptors involved in protein translocation across membranes. Mol Biol Evol 24:2763-2774. doi: 10.1093/molbev/msm211
25. Schumacher JA, Crockett DK, Elenitoba-Johnson KSJ, Lim MS (2007) Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells. Proteomics 7:2603-2616. doi:10.1002/pmic.200700108
26. Shiau AK, Harris SF, Southworth DR, Agard DA (2006) Structural analysis of E. coli hsp90 reveals dramatic nucleotide-dependent conformational rearrangements. Cell 127:329-340. doi:10.1016/ j.cell.2006.09.027
27. Sreedhai- AS, Kalmar E, Csermely P, Shen YF (2004) Hsp90 isoforms: functions, expression and clinical importance. FEBS Lett 562:11-15. doi: 10.1016/S0014-5793(04)00229-7 (Pubitemid 38388440)
28. Stebbins CE, Russo AA, Schneider C, Rosen N, Hartl FU, Pavletich NP (1997) Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell 89:239-250. doi: 10.1016/S0092-8674(00)80203-2 (Pubitemid 27199896)
29. Stepanova L, Leng X, Parker SB, Harper JW (1996) Mammalian. p50cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Gen Develop 10:1491-1502. doi:10.1101/gad 10.12.1491 (Pubitemid 26260706)
30. Te J, Jia L, Rogers J, Miller A, Hartson SD (2007) Novel subunits of the mammalian Hsp90 signal transduction chaperone. J Prot Res 6:1963-1973. doi:10.1021/pr060595i (Pubitemid 46814517)
31. Terasawa K, Yoshimatsu K, Iemiura S, Natsume T, Tanaka K, Minami Y (2006) Cdc37 interacts with the glycine-rich loop of Hsp90 client kinases. Mol Cell Biol 26:3378-3389. doi: 10.1128/ MCB.26.9.3378-3389.2006
32. Vaughan CK, Gohlke U, Sobott F, Good VM, Ali MMU, Prodromou C, Robinson CV, Saibil HR, Pearl LH (2006) Structure of an Hsp90-Cdc37-Cdk4 complex. Mol Cell 23:697-707. doi:10.1016/j.molcel.2006.07.016
33. Weinstein IB, Joe AK (2006) Mechanisms of disease: oncogene addiction - a rationale for molecular targeting in cancer therapy. Nat Clin Pract Oncol 3:448-457. doi:10.1038/ncponc0558 (Pubitemid 44203817)
34. Picard D (2008) Hsp90 interactors. http://www.picard.ch/downloads/ Hsp90interactors.pdf
35. Yang CS, Weiner H (2002) Yeast two-hybrid screening identifies binding partners of human Tom34 that have ATPase activity and form a complex with Tom34 in the cytosol. Arch Biochem Biophys 400:105-110. doi:10.1006/abbi.2002.2778
36. Ye X, Zhu C, Harper JW (2001) A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene. Proc Natl Acad Sci U S A 98:1682-1686. doi: 10.1073/pnas.041596198
37. Young JC, Obermann WMJ, Hartl FU (1998) Specific binding of tetratricopeptide repeat proteins to the C-terminal 12-kDa domain of Hsp90. J Biol Chem 273:18007-18010. doi:10.1074/ jbc.273.29.18007
38. Young JC, Hoogenraad NJ, Hartl FU (2003) Molecular chaperones Hsp90 and Hsp70 deliver preproteins to the mitochondrial import receptor Tom70. Cell 112:41-50. doi: 10.1016/S0092-8674(02) 01250-3
39. Zhao R, Davey M, Hsu Y, Kaplanek P, Tong A, Parsons AB, Krogan N, Cagney G, Mai D, Greenblatt J, Boone C, Emili A, Houry WA (2005) Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the Hsp90 chaperone. Cell 120:715-727. doi:10.1016/j.cell.2004.12. 024
40. Zhao R, Kakihara Y, Gribun A, Huen J, Yang G, Khanna M, Costanzo M, Brost RL, Boone C, Hughes TR, Yip CM, Houry WA (2008) Molecular chaperone Hsp90 stabilizes Pih1/Nop17 to maintain R2TP complex activity that regulates snoRNA accumulation. J Cell Biol 180:563-578. doi:10.1083/jcb.200709061